The program theme is to identify effective breast cancer screening strategies for women with diverse levels of breast cancer risk to maximize screening benefits while minimizing potential harms. Program aims follow the premise that breast cancer screening will be most effective when: guidelines are based on accurate risk estimates that are tied to the effectiveness and harms of screening tests;women and physicians are informed about screening test performance based on risk level;risk-based screening practices are equitable;and high-quality comparative effectiveness research results are disseminated into community practice. Program goals will be met through three complementary research projects and three shared resource cores. Project 1, Risk Assessment in Community Practice: Developing Better Models, will improve prediction of breast cancer and breast cancer subtypes among women of varying ages and race/ethnicity and evaluate whether predicted risk can be used to optimize screening outcomes. Project 2, Comparative Effectiveness of Imaging Strategies for Breast Cancer Screening in Community Practice, will characterize the performance of advanced imaging technologies and screening strategies according to age, race/ethnicity, breast density, and overall breast cancer risk. Project 3, Community-based Utilization of Breast Imaging Technologies, will assess risk-based screening in diverse populations and identify disparities in access and use of new technologies. The Administrative Core will support logistical requirements and facilitate communication and data sharing. The Biostatistics and Data Management Core will coordinate data collection, management, and analysis and will develop statistical methods. The Comparative Effectiveness Core will use simulation modeling to estimate long-term implications of different screening practices on population health. The program represents an integrated effort to improve screening with the overall aim of averting deaths from breast cancer while minimizing harms.

Public Health Relevance

The program will advance comparative effectiveness research in breast cancer screening and, in so doing, extend the evidence base for implementation of effective, high-quality medical care that will improve the health of the public by maximizing the benefits of screening while minimizing harms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA154292-04
Application #
8734249
Study Section
Special Emphasis Panel (ZCA1-GRB-S (M1))
Program Officer
Breen, Nancy
Project Start
2011-09-27
Project End
2016-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
4
Fiscal Year
2014
Total Cost
$3,657,805
Indirect Cost
$502,285
Name
Group Health Cooperative
Department
Type
DUNS #
078198520
City
Seattle
State
WA
Country
United States
Zip Code
98101
Sprague, Brian L; Arao, Robert F; Miglioretti, Diana L et al. (2017) National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology 283:59-69
Chen, Youdinghuan; Marotti, Jonathan D; Jenson, Erik G et al. (2017) Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS). Exp Mol Pathol 103:78-83
Haas, Jennifer S; Baer, Heather J; Eibensteiner, Katyuska et al. (2017) A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care. Am J Prev Med 52:100-105
Lam, Diana L; Houssami, Nehmat; Lee, Janie M (2017) Imaging Surveillance After Primary Breast Cancer Treatment. AJR Am J Roentgenol 208:676-686
Menes, Tehillah S; Kerlikowske, Karla; Lange, Jane et al. (2017) Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy. JAMA Oncol 3:36-41
Dabbous, Firas M; Dolecek, Therese A; Berbaum, Michael L et al. (2017) Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev 26:397-403
Engmann, Natalie J; Scott, Christopher G; Jensen, Matthew R et al. (2017) Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors. Cancer Epidemiol Biomarkers Prev 26:930-937
Dabbous, Firas; Dolecek, Therese A; Friedewald, Sarah M et al. (2017) Performance characteristics of digital vs film screen mammography in community practice. Breast J :
Ziv, Elad; Tice, Jeffrey A; Sprague, Brian et al. (2017) Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS One 12:e0168601
Ahern, Thomas P; Sprague, Brian L; Bissell, Michael C S et al. (2017) Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiol Biomarkers Prev 26:938-944

Showing the most recent 10 out of 164 publications